Loss of tumor suppressor genes may enable these tumor cells to reexpress developmental TFs [143] and to exhibit cell plasticity under selective pressure of potent AR inhibition (prostate) or EGFR inhibition (NSCLC). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.